New hope for rare tumor patients: drug targets desmoid growth
NCT ID NCT07170644
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 30 times
Summary
This study tests a drug called nirogacestat in 20 Japanese adults with desmoid tumors that are growing. Desmoid tumors are non-cancerous but can cause pain and disability. The goal is to see if the drug can shrink or stop the tumors. Participants take the drug by mouth and are monitored for response and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DESMOID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nagoya University Hospital
Nagoya, Aichi-ken, 466-8560, Japan
-
National Cancer Center Hospital
Chuo Ku, Tokyo, 104-0045, Japan
-
Osaka Prefectural Hospital Organization Osaka International Cancer Institute
Osaka, 541-8567, Japan
Conditions
Explore the condition pages connected to this study.